Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
16.31
+0.25 (1.56%)
At close: Jul 21, 2025, 4:00 PM
16.35
+0.04 (0.25%)
After-hours: Jul 21, 2025, 7:57 PM EDT
Teva Pharmaceutical Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$24.71
Upside
+51.50%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $24 → $23 | Strong Buy | Maintains | $24 → $23 | +41.02% | Jun 26, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +47.15% | Jun 6, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +53.28% | May 28, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $21 → $23 | Hold → Buy | Upgrades | $21 → $23 | +41.02% | May 12, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | +34.89% | May 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +22.62% | Mar 6, 2025 |
| UBS | UBS | Strong Buy Maintains $30 → $27 | Strong Buy | Maintains | $30 → $27 | +65.54% | Jan 30, 2025 |
| Barclays | Barclays | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +59.41% | Jan 30, 2025 |
| UBS | UBS | Strong Buy Maintains $28 → $30 | Strong Buy | Maintains | $28 → $30 | +83.94% | Jan 23, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $23 → $30 | Buy | Maintains | $23 → $30 | +83.94% | Jan 17, 2025 |
| Barclays | Barclays | Buy Maintains $25 → $28 | Buy | Maintains | $25 → $28 | +71.67% | Dec 18, 2024 |
| Barclays | Barclays | Buy Maintains $22 → $25 | Buy | Maintains | $22 → $25 | +53.28% | Oct 23, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $16 → $18 | Hold | Maintains | $16 → $18 | +10.36% | Oct 21, 2024 |
| UBS | UBS | Strong Buy Maintains $24 → $26 | Strong Buy | Maintains | $24 → $26 | +59.41% | Sep 3, 2024 |
| Barclays | Barclays | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +34.89% | Aug 1, 2024 |
| UBS | UBS | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +47.15% | Jul 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.